1[1]Swati BG, Ruth LG, Anthony RB, et al. CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990 - 1998. AIDS, 2000, 14: 853～ 861
2[2]Maini MK, Gilson RJC, Chavda N, et al. Reference ranges and sourses of variability of CD4 counts in HIV - seronegative women and men. Genitorin Med, 1996, 72:27～ 31
3[3]Center for Disease Control. Revision of the CDC surviellance case definition for acquired immunodeficiency syndrome. MMWR, 1987, 36(Suppl): 355
4[4]Vincenzo Pand Giuseppe I. Effect of Antiretroviral Agents on TLymphocyte Subset Counts in Healthy HIV Negative Individuals. Journal of Acq Immunodef Syn, 2000, 24:440～443
5[5]Mark Harrington, Charles CJ Carpenter. Hit HIV - 1 hard, but only when necessary. The Lancet, 2000, 355:2 147～2 152
6[6]Lucas GM, Chaisson RE, Moore RE. Highly active antiretroviral therapy in a large urban clinic:risk factors for virologic failure and adverse drug reaction. Ann Intern, 1999,131: 81 ～ 87
7[7]Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir of human immunodeficiency virus- 1 in patients on highly active antiretrovial therapy. Science, 1997,278:1 295～ 1 300
8[8]CDC. 1999 USPHS guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. US Public Health Service and Infectious Disease Society of America. MMWR Morb Mortal Wkly Rep, 1999, 48(RR - 10): 1 ～ 82
9[9]Carpenter CC, Fischi MA, Hammer SM, et al. Antiretrviral therapy for HIV infection in 1996: recommendations of an international panel. JAMA, 1996, 276:146～ 153
10[10]Heller L, Fox S, Hell KJ, et al. Development of an instrument to assess nutritional risk factors for children infected with human immunodificiency virus. J Am Diet Assoc, 2000,100:323～ 329
